Trial intelligence / Profile preview

PK of Bisacodyl and Sodium Picosulfate in Lactating Women

NCT02211911Phase 1Completed

Sponsor
Boehringer Ingelheim
Start
Feb 2008
Primary completion
May 2008
Modality
Small Molecules
01

Overview

Phase 1, open-label trial of bisacodyl and sodium picosulfate in constipation (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration in plasma up to 8 days, Time to maximum concentration up to 8 days and 5 more. Started Feb 2008; status: completed.

02

Drugs

bisacodylsodium picosulfate
03

Conditions

constipation

Beyond the preview

Go deeper on NCT02211911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02211911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call